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Unexplained intrauterine growth restriction of the
fetus (IUGR) results from impaired placental develop-
ment, frequently associated with maternal malperfu-
sion. Some cases are complicated further by pre-
eclampsia (PEIUGR). Here, we provide the first
evidence that placental protein synthesis inhibition
and endoplasmic reticulum (ER) stress play key roles
in IUGR pathophysiology. Increased phosphorylation
of eukaryotic initiation factor 2 suggests suppres-
sion of translation initiation in IUGR placentas, with
a further increase in PEIUGR cases. Consequently,
AKT levels were reduced at the protein, but not
mRNA, level. Additionally, levels of other proteins in
the AKT-mammalian target of rapamycin pathway
were decreased, and there was associated dephos-
phorylation of 4E-binding protein 1 and activation of
glycogen synthase kinase 3. Cyclin D1 and the eu-
karyotic initiation factor 2B epsilon subunit were also
down-regulated, providing additional evidence for
this placental phenotype. The central role of AKT
signaling in placental growth regulation was con-
firmed in Akt1 null mice, which display IUGR. In
addition, we demonstrated ultrastructural and molec-
ular evidence of ER stress in human IUGR and
PEIUGR placentas, providing a potential mecha-
nism for eukaryotic initiation factor 2 phosphoryla-
tion. In confirmation, induction of low-grade ER
stress in trophoblast-like cell lines reduced cellular
proliferation. PEIUGR placentas showed elevated ER
stress with the additional expression of the pro-apop-
totic protein C/EBP-homologous protein/growth ar-
rest and DNA damage 153. These findings may ac-
count for the increased microparticulate placental
debris in the maternal circulation of these cases, lead-
ing to endothelial cell activation and impairing pla-
cental development. (Am J Pathol 2008, 173:451–462;
DOI: 10.2353/ajpath.2008.071193)
Intrauterine growth restriction (IUGR), defined as failure
of a fetus to reach its genetic growth potential, affects 4 to
7% of births. It can occur in isolation or in association with
maternal hypertensive disorders, such as preeclampsia
(PEIUGR), and remains a leading cause of perinatal
morbidity and mortality.1 As the interface between a
mother and her fetus, the placenta is critical for fetal
nutrition. Thus, during human pregnancy, reduced pla-
cental growth precedes fetal IUGR.2,3 There are many
potential causes of human IUGR, including maternal
smoking, undernutrition, infection, or congenital malfor-
mations, but the majority of cases remain unexplained.
Nonetheless, these are frequently associated with defi-
cient conversion of the maternal spiral arteries supplying
the placenta.4,5 We recently proposed that this failure
results in excessive spontaneous constriction of the ar-
teries, exposing the placenta to low-grade repetitive isch-
emia-reperfusion (I/R) injury.6 I/R is a powerful generator
of ROS (reactive oxygen species), and oxidative stress is
increased in IUGR placentas, and further so in PEIUGR
placentas.7
I/R also depletes intracellular ATP concentrations. One
of the consequences of I/R is induction of endoplasmic
reticulum (ER) stress. The ER serves many specialized
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functions in the cell including synthesis, folding and
transport of membrane and secretory proteins, and se-
questration of calcium ions (Ca2). The mechanisms un-
derlying I/R activation of ER stress have been explored in
other systems, especially the brain.8 Both depletion of
ATP and generation of ROS reduce Ca2 storage within
the ER compartment by inhibition of ATP-dependent sar-
coplasmic/endoplasmic reticulum Ca2-ATPases.8,9 In
the ER lumen, loss of Ca2 homeostasis and low ATP
concentrations suppress ATP and Ca2-dependent post-
translational modifications, including disulfide bond for-
mation, N-linked glycosylation and controlled proteolysis.
As a result misfolded proteins accumulate, provoking ER
stress response pathways or the unfolded protein
response.10–12
The unfolded protein response attempts to restore ER
homeostasis and involves activation of three highly con-
served signaling pathways.9,13 The first aims to reduce
the burden of new proteins entering the ER lumen through
translational attenuation. This is achieved through phos-
phorylation of eukaryotic initiation factor (eIF)2 (P-eIF2)
by activation of PRKR-like endoplasmic reticulum kinase
(PERK),14 and prevents binding of the initiator Met-tRNA to
the ribosome.15 The second enhances the protein folding
capacity by increasing ER chaperone proteins, such as
glucose-regulated protein 78/binding immunoglobulin pro-
tein (GRP78) and glucose-regulated protein 94 heat shock
protein 90 kDa beta 1(GRP94), and the folding enzymes, such
as protein disulfide isomerase and peptidyl-prolyl isomerase.
Expression of theseproteins is regulated throughactivation of
activating transcription factor 6 and X-box binding pro-
tein-1 (XBP-1), a second transcription factor that is a
marker of ER stress especially in relation to hypoxia.13
The third pathway promotes degradation of the remaining
unfolded or misfolded proteins through increased capac-
ity of the cytosolic ubiquitin-proteosome system.16,17
However, when ER function is severely impaired, apopto-
sis is induced to eliminate damaged cells. Again, multiple
pathways are involved, including increased expression of
the transcription factor C/EBP homologous protein/growth
arrest and DNA damage 153 (CHOP),18 which in turn sup-
presses expression of the anti-apoptotic gene, Bcl-2.19
There may also be activation of the Ire1-TRAF2-ASK1-MAP
kinase pathway,20 and of ER-associated caspase-4 (in
human)21 or caspase-12 (in mouse).22
Recently, we showed that I/R induces ER stress in the
human trophoblast-like cell line, JEG-3 choriocarcinoma
cells, and that this is associated with inhibition of protein
synthesis.23 One of the consequences we observed was
reduced concentrations of both phosphorylated and total
AKT. AKT signaling plays a central role in the regulation
of cell growth and proliferation by integrating the actions
of growth factors and functioning as an ATP and amino
acid sensor to fine tune protein synthesis to nutrient avail-
ability via control of the mammalian target of rapamycin
(mTOR) pathway and glycogen synthase kinase 3
(GSK-3) activity, respectively.24–27 In the mouse homozy-
gous disruption of the Akt1 gene causes IUGR.28
mTOR signaling regulates a number of components of
the translational machinery. AKT acts as an upstream
kinase that controls mTOR activity via two distinct mech-
anisms. Firstly, AKT can phosphorylate mTOR directly at
serine 244829 although the importance of this is conten-
tious.30 Secondly, AKT phosphorylates tuberous sclero-
sis complex (TSC)2/tuberin at threonine 1462.31 TSC2 is
one component of a dimeric complex that also contains
TSC1/hamartin. In its unphosphorylated state it is thought
to serve as a GTPase activating protein for the small G
protein, ras homolog enriched in brain (Rheb). Rheb, in
its GTP-bound state, activates mTOR.32,33
In mammalian cells, mTOR exists in at least in two
distinct complexes; mTOR complex 1 (mTORC1) contain-
ing the partner protein regulatory associated protein of
mTOR (raptor), and mTORC2, containing the partner ra-
pamycin-insensitive companion of mTOR (rictor). It is
mTORC1 that regulates protein translation, and it may act
via at least three mechanisms. First, activation of
mTORC1 promotes cap-dependent translation initiation
through phosphorylation of 4E binding protein 1 (4E-
BP1), preventing its complexing with eukaryotic initiation
factor 4E (eIF4E).26 Second, mTORC1 also modulates
initiation through the phosphorylation of multiple serine
residues in the C terminus of eIF4G providing an addi-
tional mechanism for fine tuning the protein synthesis
rate.34 Finally, the ribosomal protein S6 kinase 1 (S6K1,
also known as p70RSK), but not S6 kinase 2 (S6K2, also
known as p90RSK), is a substrate of mTORC1. S6Ks phos-
phorylate eukaryotic elongation factor 2 kinase (eEF2K),
which in turn phosphorylates and inactivates eEF2, pre-
venting translation elongation.35 In contrast, mTORC2
does not involve any direct role in controlling the protein
translation. However, its function seems to provide posi-
tive feedback by maintaining AKT activity through phos-
phorylation at serine 473.36 Multiallelic disruption of rictor,
the key component in mTORC2, induces embryonic le-
thality at E11, resulting from impaired AKT activity.37
Besides regulating mTOR activity, AKT can also influ-
ence protein translation indirectly through GSK-3. AKT
phosphorylates both GSK-3 isoforms (, serine 21, and ,
serine 9) at their N termini, inhibiting their activities.
eIF2B (eukaryotic initiation factor 2B subunit epsilon) is
substrate of GSK-3, and is crucial for the regeneration of
active eIF2.GTP from its inactive eIF2.GDP form in the
initiation step of translation machinery.38 Phosphorylation
inhibits its activity,39 and will be promoted by low AKT
levels. Loss of function mutations in the epsilon and beta
subunits of eIF2B result in a reduction of protein synthe-
sis, and are the major cause of a human inherited genetic
disease termed ‘vanishing white matter.’ Interestingly,
IUGR is associated with this disease.40,41
We hypothesize, therefore, that deficient conversion of
the spiral arteries causes a low-grade I/R injury to the
placenta that activates phosphorylation of eIF2. Subse-
quent inhibition of protein translation leads to reduced
AKT signaling, suppressing activity in the mTOR and
GSK-3 pathways and further reinforcing attenuation of
protein synthesis through modulation of components of
the translation initiation and elongation machinery, in-
cluding eIF2B, 4E-BP1, and eEF2K. Activation of P-
eIF2 in the pathological placentas may occur through
induction of ER stress secondary to oxidative stress.
Evidence of ER stress includes increases in the proteins,
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GRP94 and C/EBP homologous protein (CHOP), an in-
crease in the spliced variant of Xbp-1 mRNA, and dilated
ER cis ternae. Ultimately, reduced concentrations of cell
cycle regulatory proteins such as cyclin D1 would result
in slowing of cell proliferation. This is confirmed by induc-
tion of low-grade ER stress through I/R in choriocarci-
noma cells. If maintained over a period of weeks or
months in utero we predict these effects would have a
dramatic impact on placental, and hence fetal, growth.
Materials and Methods
Sample Collection
Samples were collected with informed written consent of
the patients and Local Ethical Committee approvals. All
placentas were delivered by elective caesarean section
from non-laboring singleton pregnancies. IUGR was di-
agnosed ultrasonically when abdominal circumference
measurements were below the 10th percentile,42 and
confirmed at birth by a neonatal weight below the 10th
percentile.43 Severity of IUGR was evaluated by Doppler
velocimetry of the umbilical artery and by fetal heart rate, as
previously described.44 Of the six IUGR cases, three had
normal umbilical artery Doppler velocimetry and normal
fetal heart rate, one had absent end diastolic blood flow of
the umbilical artery but normal fetal heart rate and two had
abnormal umbilical arterial Doppler velocimetry and abnor-
mal fetal heart rate. On the maternal side, four displayed
abnormal uterine artery Doppler blood flow velocimetry,
confirming deficient conversion of the spiral arteries.
Preeclampsia (PEIUGR) was defined as the onset of
gestational hypertension and proteinuria after 20 weeks
of gestation, and the cases examined also included all of
the criteria for IUGR. Hypertension was defined as two or
more recordings of a diastolic blood pressure of 90
mmHg or more taken at least 4 hours apart. Proteinuria
was taken as the excretion of 300 mg protein or more
over a 24-hour period. Of the six PEIUGR cases, one
had normal umbilical artery Doppler velocimetry and nor-
mal fetal heart rate, one had absent end diastolic blood
flow of the umbilical artery but normal fetal heart rate, and
four had abnormal umbilical arterial Doppler velocimetry
and abnormal fetal heart rate.
Controls were from normotensive term pregnancies
delivering appropriate for gestational age fetuses that
displayed no abnormality on routine scans.
In all pregnancies gestational age was calculated from
the last menstrual period and confirmed by routine ultra-
sonography at 11 to 12 weeks of gestation. Exclusion
criteria for both controls and IUGR were: fetal chromo-
somal abnormalities, pre- and postnatal malformations or
phenotypic anomalies, and maternal diseases predis-
posing to IUGR, such as autoimmune diseases, throm-
bophilic conditions, and diabetes.
Cell Culture
The human choriocarcinoma JEG-3 cells were cultured
as previously described.23 Human choriocarcinoma JAR
cells were a gift from Dr. Ashley Moffett and were grown
in RPMI 1640 medium (Invitrogen Ltd, Paisley, UK) sup-
plemented with 5% heat-inactivated fetal bovine serum
(Invitrogen), penicillin (100 U/ml), and streptomycin (100
g/ml) at 37°C in a 5% CO2 atmosphere.
Electron Microscopy
Samples from normal and IUGR placentas were fixed
immediately after delivery in 2.5% glutaraldehyde in 0.1M
cacodylate buffer for 4 hours, postfixed in 1% osmium
tetroxide and then embedded in Araldite resin. The pla-
centas were from non-smokers who delivered at term by
caesarean section. Thin sections were stained with lead
citrate and uranyl acetate, and viewed in a Philips CM100
microscope (Eindhoven, The Netherlands).
Western Blot
Western blotting analysis of protein expression and ki-
nase phosphorylation was preformed as previously de-
scribed.23 -actin or Ponceau red staining was used to
normalize protein loading. All phospho-specific and other
antibodies were from Cell Signaling Technology (Dan-
vers, MA) except where specifically mentioned. Anti-
actin antibody was from Sigma-Aldrich (Poole, UK). Anti-
C/EBP- homologous protein/growth arrest and DNA dam-
age 153, phospho-eIF2B (Ser539), and eIF2B antibodies
were from Abcam (Cambridge, UK).
RT-PCR Analysis of Xbp-1 mRNA Splicing
The assay was performed as previously described.23
Quantitative Real-Time RT-PCR Analysis
The assay was conducted as previously described.23
Pulse 35S-Methionine Labeling
JEG cells were incubated for 21 hours in the presence or
absence of 75 mol/L salubrinal (ChemBridge Corporation,
San Diego, CA, USA) or 10 g/ml cycloheximide (Sigma).
Cells were then washed and incubated with cysteine and
methionine-free RPMI 1640 medium (Sigma) for 10 minutes
in the presence of inhibitors twice before being pulsed with
[35S]methionine by incubation with cysteine and methio-
nine-free RPMI 1640 medium (Sigma) containing translation
grade [35S]methionine (Amersham Biotech, Munich, Ger-
many) and cysteine in the presence of inhibitors for 1 hour.
After extensive washing with RPMI 1640medium, cells were
lysed in lysis buffer (refers to Western blotting). Equal
amounts of protein from different samples were resolved
using SDS-polyacrylamide gel electrophoresis. The gel was
stained with 0.25% (w/v) Coomasie Brilliant Blue R 250 to
show an equal protein loading between the samples, and
the dried gel was exposed to a phosphorimager screen
(Molecular Dynamics, Sunnyvale, CA, USA). Image was
captured and analyzed using ImageQuant software (Molec-
ular Dynamics).
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Akt1/ Mice
These were prepared as described.28 Placentas were
collected at E18.5, weighed and snap-frozen in liquid
nitrogen before analysis.
Measurement of Cell Proliferation
Cells were counted using a hemocytometer. All 18 fields
from two grids, each containing nine squares were
counted, and two duplicates were used in each
condition.
Statistical Analysis
Differences between means were tested using either two-
tailed Student’s t-test, or nonparametric Mann Whitney-
U-test, with P  0.05 being considered significant.
Results
Increased Phosphorylation of eIF2 Inhibits
Protein Synthesis and Reduces Cell Proliferation
in Pathologic Placentas
Samples from six normotensive IUGR, six PEIUGR, and
six normal placentas, all delivered by elective caesarean
section, were studied. Their gestational ages were; IUGR
28 to 38 weeks, PEIUGR 26 to 35 weeks, and controls
39 weeks (Table 1). Phosphorylation of eIF2 at Ser51
was increased in the IUGR and PEIUGR placentas by
3.9 and 6.9 times, respectively, whereas eIF2 remained
relatively constant compared to non-pathological con-
trols (Figure 1, A and B). The levels in IUGR and
PEIUGR placentas also differed significantly. Phos-
phorylation of eIF2 is associated with protein synthesis
inhibition (PSI), which can lower the levels of cell cycle
regulatory proteins.45,46 We found an approximately 75%
and 85% reduction in cyclin D1 protein, in the IUGR and
PEIUGR placentas, respectively (Figure 1, A and B).
To test whether P-eIF2 reduces proliferation of tro-
phoblast cells two trophoblast-like cell lines, JEG-3 and
JAR cells, were incubated with salubrinal, an inhibitor of
eIF2 dephosphorylation.47 Incubation of JEG-3 cells
with salubrinal increased P-eIF2 at Ser51 (Figure 1C, left
panel), and cell number reduced by approximately 48%
after 48 hour (Figure 1C, right graph). Double staining
with propidium iodide and Hoechst 33348 revealed no
increase in cell death compared to untreated cultures
(data not shown). Similar results were obtained using the
JAR cells (data not shown).
To examine whether the salubrinal reduced cell prolif-
eration through PSI, a 35S-labeled methionine pulse ex-
periment was preformed. JEG-3 cells were pretreated
with either salubrinal or cycloheximide for 21 hours be-
fore incubation in medium containing 35S-methionine for
1 hour. The autoradiograph revealed that salubrinal in-
Table 1. Clinical Characteristics of the Study Participants
Normal IUGR IUGRPE
Gestation age (weeks) 39  0.6 32  3.5** 31  3.3**
Fetal weight (gram) 3615  417 1045  465** 1034  495**
Placental weight (gram) 629  91 223  42** 178  59**
Umbilical artery Doppler Normal  6 Normal  3 Normal  1
PEDF  2 PEDF  4
AREDF  1 AREDF  1
PEDF  Abnormal but present end diastolic blood flow; AREDF  Absent or reversed end diastolic blood flow.
Data are mean  SD; **P  0.001.
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Figure 1. Increased P-eIF2 at Ser51 inhibits protein synthesis and reduces
cell proliferation in pathological placentas. A: Western blot showing in-
creased P-eIF2 (Ser51) with constant levels of eIF2, and reduced cyclin D1
in both IUGR and PEIUGR placentas. B: Densitometry of bands expressed
relative to normal controls (100%). Phosphorylation status is presented as the
ratio between phosphorylated and total protein, both normalized to -actin.
Data are mean  SEM for six placentas per group. C: Salubrinal treatment
slows cell proliferation in JEG-3 cells. Cell numbers were compared to the
untreated control (100%). D: Protein translation is halted under eIF2 phos-
phorylation. Cells were exposed for 1 hour to [35S]methionine before protein
extraction. Whole cell lysates were used to show an equal input of protein.
Data are mean  SEM for three independent experiments. **P  0.01.
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duced general protein synthesis inhibition. Densitometric
analysis showed a 22% suppression of global protein
translation, while cycloheximide, a positive control, atten-
uated it by over 53% (Figure 1D).
These data confirmed an increase in P-eIF2 in patho-
logical placentas, and that this is sufficient to reduce
trophoblastic cell proliferation in vitro through suppres-
sion of protein translation.
Loss of AKT Protein in IUGR Placentas Results
from Protein Synthesis Inhibition
Increased P-eIF2 with salubrinal treatment also down-
regulated AKT protein concentration in JEG-3 cells (Fig-
ure 1C, left panel). Therefore, it is of interest to examine
AKT protein concentration in the IUGR placentas. We
observed a 41% decrease in AKT total protein (Figure 2,
A and B). AKT protein has three different isoforms,
AKT1-3, and all isoforms were reduced in the IUGR pla-
centas to different extents (Figure 2A). Both AKT1 and
AKT2 fell by approximately 40%, while AKT3 was re-
duced by over 90% (Figure 2B). The reduction of AKT
protein concentration was accompanied by a loss of its
kinase activity, as indicated by a 90% reduction in
phosphorylation of its down-stream target substrate,
GSK-3 at Ser9 (Figure 2, A and B). We also observed a
30% reduction in GSK-3 protein.
One of GSK-3 downstream substrates is the eIF2B
subunit. Phosphorylation of eIF2B at serine 539
reduces its guanine nucleotide-exchange activity,
thereby suppressing translation initiation.48 The eIF2B
antibody recognized three bands at 75 kDa, 73 kDa,
and 50 kDa; the latter two are suggested by the man-
ufacturer to be cleaved fragments of eIF2B (Figure
2A). We observed a greater than 60% reduction in the
eIF2B 75 kDa band in the IUGR placentas (Figure 2B).
The relative phosphorylation level of the eIF2B at
Ser539 increased by approximately 1.8 times in the
IUGR placentas, but this did not reach statistical sig-
nificance due to high variability between samples.
Nonetheless, the reduction in eIF2B protein alone
would be sufficient to reduce eIF2B guanine nucleotide
exchange activity.
To determine whether the loss of AKT proteins was the
result of transcriptional suppression or through other
mechanisms, transcript levels of all three AKT isoforms
were quantified by real-time quantitative RT-PCR. No dif-
ferences were found between IUGR and normal placen-
tas (Figure 2C), confirming that loss of AKT proteins did
not result from transcriptional inhibition. It is also unlikely
to be the result of increased degradation as Hass and
Sohn49 reported reduced proteosomal activity in IUGR
and preeclamptic placentas. We recently demonstrated
that P-eIF2 directly attenuates AKT protein translation in
JEG-3 cells,23 suggesting that the loss of AKT proteins in
IUGR placentas is most likely due to translational
inhibition.
Reduction of mTOR Signaling Suppresses
4E-BP1 Phosphorylation but Not Activity of
S6 Kinases
Besides influencing the AKT-GSK3-eIF2B pathway, AKT
also tunes the protein synthesis rate through regulation of
mTOR signaling. Both mTOR Ser2448 and TSC2 Thr1462
phosphorylation sites are direct substrates of the kinase
AKT.29,31 Activity of mTORC1 depends not only on the
activity of mTOR kinase and raptor protein level, but also
on removal of an inhibitory complex TSC2/TSC1. In IUGR
placentas, mTOR and P-mTOR at Ser2448, TSC2 and
P-TSC2 at Thr1462, and raptor protein were all de-
creased as compared with controls (Figure 3, A and B).
Dephosphorylation of TSC2 at Thr 1462 promotes bind-
ing of TSC2 to mTORC1, and the combined result was
that activation of the downstream effector, P-4E-BP1 at
Thr37/46, was reduced by approximately 75% in IUGR
placentas, while 4E-BP1 remained constant (Figure 3, A
and B). Multiple bands indicative of additional phosphor-
ylation sites were observed for both P-4E-BP1 and 4E-
BP1, as shown in antibody datasheets, and all were
included in the quantification.
mTORC1 can also regulate the activity of the S6K1,
which in turn provides an addition mechanism to con-
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Figure 2. Protein synthesis inhibition induces loss of AKT-GSK-3 signaling
in IUGR placentas. A: Western blotting revealed reduced AKT isoforms,
P-GSK-3, GSK-3 eIF2B  subunit and P-eIF2B in IUGR placentas. B:
Densitometry of band intensity in IUGR expressed relative to normal controls
(100%). Phosphorylation status is presented as the ratio between phosphor-
ylated and total protein, both normalized to -actin. C: Quantitative real-
time-PCR revealed no difference in transcript levels for the three AKT iso-
forms in IUGR. Data are mean  SEM for six placentas per group. *P  0.05,
**P  0.01, n.s indicates non-significant change.
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trol protein translation. Both ribosomal protein S6 and
eEF2K are substrates of the S6Ks.35 In IUGR, although
the levels of P-S6 and S6 protein were not significantly
changed compared to controls, there was a trend to-
ward an increase, rather than the expected decrease,
in the P-S6/S6 ratio (Figure 3, A and B). This suggested
possible activation of the S6Ks, which was confirmed
by the significant increase in ratio of P-eEF2K/eEF2K
(Figure 3B). However, total eEF2K protein was signifi-
cantly decreased, indicating a reduction in overall
eEF2K activity in IUGR placentas (Figure 3, A and B).
This implies an increase of eEF2 activity, which may
facilitate translation elongation in those placentas.
Decreased Akt Protein Reduces mTOR
Signaling and Impairs Murine Placental
Growth
Akt1 null, but not Akt2 or Akt3 null, mice exhibit a late-
onset IUGR phenotype, confirming the important role of
Akt signaling in both placental and fetal growth.28 Al-
though it has been reported that the IUGR arises primarily
due to a compromise of placental vascularization,28 we
investigated whether knock-out of Akt1 protein in mice
may also result in impairment of mTORC1 signaling and
4E-BP1 phosphorylation, thereby slowing placental growth
via translation inhibition.
In our sample of E18.5 placentas from Akt1 null
(Akt1/) mice placental mass was reduced by 45%
compared to wild-type (WT) (Figure 4A). Akt1 appears
to be the major Akt isoform in the mouse placenta as
total Akt protein was reduced by over 90% in Akt1/
placentas (Figure 4B). In addition, P-Akt at both Ser473
and Thr308 fell by more than 80% (Figure 4B). Inter-
estingly, the protein levels of Akt2 and Akt3 increased
by 50% and 60% respectively in the Akt1/ placen-
tas, suggesting a compensatory mechanism (Figure 4,
B and C). This decrease of Akt signaling was associ-
ated with reductions in phosphorylation of TSC2 at
Thr1462, and 4E-BP1 at Thr37/46, of 50% and 60%
respectively, equivalent to our observations in the hu-
man IUGR placentas (Figure 3B).
We observed a large variation in the mass of both
wild-type (WT) and Akt1/ placentas, both within and
between litters. Variation within a litter reached 20%, (78
to 91.8 mg in WT and 40.8 to 51.7 mg in Akt1/) and
between litters was up to 40% (78 to 110.4 mg in WT). To
determine whether Akt activity relates to this variation in
placental mass we measured the Akt phosphorylation
level at both Ser473 and Thr308 from 12 mouse placen-
tas with different Akt1 genotypes. A strong positive cor-
relation was found between placental weight and both
P-Akt(S473) and P-Akt(T308) (R2  0.88 and 0.84 re-
spectively), but not with total Akt protein (Figure 4D).
These data demonstrate that AKT activity plays a central
role in regulating placental development via mTOR
signaling.
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The question remained as to how P-eIF2 is activated
in the IUGR placentas, initiating this cascade of down-
stream consequences.
A Gradation of ER Stress in IUGR Alone and
Preeclampsia with IUGR Placentas
Before investigating the placental tissues for evidence of
ER stress, we verified how cellular biomarkers relate to its
severity. An increase of ER chaperone proteins GRP78
and GRP94, expression of CHOP protein, and splicing of
Xbp-1 mRNA are all biomarkers of ER stress.23 Anti-
KDEL antibody is widely used to detect both GRP78 and
GRP94 by recognizing the KDEL domain at the end of C
termini of the chaperones.
Tunicamycin induces ER stress by inhibition of
N-linked glycosylation, and we performed a dose-re-
sponse study incubating JEG-3 cells in the absence or
presence of tunicamycin for 24 hours. Increased concen-
trations were closely associated with increased levels of
CHOP, GRP78 and GRP94 proteins, and splicing of
Xbp-1 mRNA (Figure 5A, left panel). As expected, there
was a gradual increase of apoptotic cell death in JEG-3
cells (Figure 5A, left panel), mediated possibly through
CHOP.
There was a progressive elevation of P-eIF2 at Ser51.
When the data were plotted on a Log scale, there were
strong positive correlations between the levels of
P-eIF2, CHOP, GRP78, and GRP94 proteins, but nega-
tive correlations with cell survival (Figure 5A, right graph).
These data strongly suggest that the greater the severity
of ER stress, the higher the level of P-eIF2, and that
when the stress reaches a certain level it induces apo-
ptotic cell death. Therefore, we questioned whether the
higher level of P-eIF2 observed in the PEIUGR pla-
centas in Figure 1, A and B was the result of greater ER
stress.
Using transmission EM, we found the ER cis ternae
within the syncytiotrophoblast to be markedly dilated in
both IUGR and PEIUGR placentas, similar to Lister’s
findings50 (Figure 5B). We did not observe equivalent
dilation within the cytotrophoblast cells, or the cells of the
villous core. By contrast, mitochondria within the syncy-
tiotrophoblast displayed normal appearances, with regu-
larly arranged cis ternae and narrow intracistal spaces.
Thus, the dilation of the ER appeared to be cell-type
specific, and could not be accounted for by a delay in
tissue fixation. Visual comparison indicated that the size
of the dilated cis ternae was greater in the PEIUGR
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placentas than in those from IUGR alone, suggesting
greater loss of ionic homeostasis within the former.
This view was supported by the molecular biomarkers.
GRP94 was elevated in the PEIUGR placentas com-
pared to both normal and IUGR placentas (Figure 5, C
and D, left graph), but no change in GRP78 protein
(Figure 5, C and D, left graph). We also observed a
2.9-fold elevation of CHOP protein in PEIUGR placen-
tas, but not in the IUGR placentas (Figure 5, C and D, left
graph). Apoptosis is significantly higher in PEIUGR
than in IUGR placentas, although estimates vary depend-
ing on the criteria used.51 CHOP requires translocation to
the nucleus to regulate gene expression. Immunohisto-
chemistry revealed an increase in CHOP staining in the
nuclei of both the syncytiotrophoblast and the fetal endo-
thelial cells in the PEIUGR placentas (Figure 5E). There
was also a significant increase in splicing of Xbp-1 mRNA
in IUGR and PEIUGR placentas compared to the con-
trols (Figure 5, C and D, right graph), with a trend to even
higher splicing in the latter although this difference was
not statistically significant.
To conclude, the ultrastructural findings and increased
expression of CHOP and GRP94 proteins suggest a
greater degree of ER stress in the PEIUGR placentas.
Syncytiotrophoblast is not the only cell type that suffers
ER stress, for we also observed an increase of immuno-
reactivity of CHOP in the fetal endothelial cells. ER stress
might thus contribute to the increased trophoblastic ap-
optosis and fetal vascular remodeling observed in
PEIUGR placentas through induction of CHOP.
Low-Grade ER Stress Reduces Cell Proliferation
Although an increased rate of apoptosis could account
for the smaller placental size in PEIUGR (Table 1), the
question arises as to how the lower levels of ER stress
that do not induce apoptosis cause equivalent smaller
sized placentas in IUGR pregnancies. In the tunicamycin
dose-response study, at a dose of 0.31 g/ml, there were
increases in P-eIF2, GRP78 and GRP94 proteins, and
splicing of Xbp-1 mRNA without induction of CHOP and
apoptosis (Figure 5A). Therefore, we investigated the
effect of this sublethal dosage of tunicamycin (referred to
as low-grade ER stress) on cell proliferation. With in-
creasing length of incubation up to 48 hours there was a
gradually elevation of GRP 78 and GRP 94 proteins, while
CHOP was not detected throughout (Figure 6A). P-eIF2
peaked at 24 hours and declined slowly at 48 hours
(Figure 6A). Strikingly, relative cell number was reduced
by more than 50% following 48 hours of tunicamycin
treatment compared to the untreated cells (Figure 6B). To
eliminate a drug and cell-type specific effect, experi-
ments were also performed using dithiothreitol, which
prevents disulfide bond formation, and were repeated in
JAR cells. Similar results were obtained (data not shown).
Interestingly, JAR cells tolerated a threefold higher con-
centration of tunicamycin than JEG-3 cells, but applica-
tion of a sublethal dose (1 g/ml) for 48 hours reduced
proliferation by 44% 5 (average range, n 2). These
data show that low-grade ER stress slows placental cell
growth without induction of cell death. The different tol-
erance of ER stress in different cell types might explain
why only certain placental cell types suffer ER stress.
Importantly, the data highlighted that the effects of ER
stress persist even after the activating signals to eIF2
have eased.
Repetitive Hypoxia/Ischemia-Reperfusion
Causes Sustainable Activation of eIF2
Phosphorylation and Reduces Cell Proliferation
Although we have demonstrated that ischemia is a potent
activator of eIF2 phosphorylation in JEG-3 cells, the
phosphorylation status falls to basal levels during the first
3 hours of re-oxygenation. Nonetheless, approximately
25% of the cells undergo apoptosis after 24 hour of
re-oxygenation.23 As most cases of unexplained IUGR
are associated with deficient conversion of the spiral
arteries we speculate that repetitive hypoxia/ischemia-
reperfusion (H/I-R) is the likely precipitating insult rather
than a single episode.6 Therefore, we used media con-
taining 10% of the normal glucose concentration with
0.5% and 21% O2 to perform H/I-R in a 3-hour cyclical
pattern with JEG-3 cells for 48 hours to mimic the phys-
iological environment in vivo. Repetitive H/I-R strongly
activated eIF2 phosphorylation at serine 51 (Figure 6C).
Consistently, it also down-regulated total AKT protein
concentration (Figure 6C), but there was no induction of
CHOP expression (Figure 6C). Crucially, unlike 48 hours
of hypoxia, which induced approximately 20% cell death
in JEG-3 cells, repetitive H/I-R did not trigger apoptosis or
necrosis (data not shown). Instead, we observed a 40%
reduction of cell proliferation (Figure 6D). These results
confirm that repetitive H/I-R induces low-grade ER stress
0%
20%
40%
60%
80%
100%
120%
Co
ntr
ol
Tu
nic
am
yci
n 
**
R
el
at
iv
e 
ce
ll 
nu
m
be
r
6      12     24    48 conTime (hr)
Anti-P-eIF2α (Ser51)
Anti-eIF2α
Anti-Akt
Anti-CHOP
Anti-KDEL
Ponceau’s Red 
Staining
Tunicamycin (0.31µg/ml)
94 
78
BA
0%
20%
40%
60%
80%
100%
120%
Normoxia H/I-R
R
el
at
iv
e 
ce
ll 
nu
m
be
r
**
Anti-P-eIF2α (Ser51)
Anti-CHOP
     N    H/I-R
Anti-Akt
Anti-eIF2α
Anti-β-actin
DC
Figure 6. Low-grade ER stress induced by either sublethal dosage of tunica-
mycin or repetitive H/I-R reduces cell proliferation in JEG-3 cells. A and B:
Sublethal dosage (0.3125 g/ml) with tunicamycin for 48 hours. C and D:
Repetitive H/I-R in a 3-hour cyclical pattern at 0.5% and 21% O2 in the
presence of 1.1 mmol/L glucose for 48 hours. A and B:Western blot showing
increased eIF2 phosphorylation, decreased Akt protein, and no induction in
CHOP. B and D: Cell numbers were compared to the untreated control
(100%). Data are mean  SEM for three independent experiments. **P 
0.01.
458 Yung et al
AJP August 2008, Vol. 173, No. 2
equivalent to that seen using sublethal dosage of tunica-
mycin and in human IUGR placentas, including in-
creased P-eIF2, decreased AKT protein, reduced cell
proliferation but no induction of CHOP protein or cell
death.
Discussion
This is the first study demonstrating evidence that PSI
and the unfolded protein response play a major role in the
pathophysiology of complications of human pregnancy,
in particular IUGR. Increased P-eIF2 in the placenta
induces an acute PSI that leads to suppression of AKT
and proteins/kinases in the mTOR pathway. Reduced
activity in this pathway leads ultimately to reduced phos-
phorylation of 4E-BP1, which in turn inhibits cap-depen-
dent translation. This mechanism provides a positive
feedback loop that enhances the PSI, and ensures no
translation under conditions of stress even in nutrient
enriched conditions. PSI is further reinforced by the re-
duction of eIF2B subunit protein level and increased
GSK-3 activity, thereby preventing guanine nucleotide-
exchange in the initiation stage of protein translation.
Down-regulation of cyclin D1 facilitates cell cycle arrest,
which in addition to the reduction of AKT activity will
compromise cell proliferation.
The end result will be a smaller placental size, the
phenotype of IUGR. In addition, we have clearly demon-
strated the existence of low-grade ER stress in IUGR
placentas by both ultrastructural analysis and the results
of ER stress biomarkers. Dilation of the ER lumen is seen
during periods of ischemia in trophoblast and other cell
types, where it is associated with activation of the un-
folded protein response.23,52 This stress is more severe
in PEIUGR placentas. ER stress activates phosphory-
lation of eIF2, and so is a strong candidate for mediation
of the PSI following hypoxia/ischemia-reperfusion. In tro-
phoblast-like cell lines induction of low-grade ER stress
reduces cell proliferation, while more severe stress trig-
gers apoptosis through expression of CHOP protein. Ap-
optotic syncytiotrophoblastic debris shed into the mater-
nal circulation as microvillous fragments can impair
maternal vascular endothelial function.53 The degree of
ER stress may therefore be a critical factor that deter-
mines whether IUGR pregnancies are complicated by
preeclampsia or not (Figure 7).
In this study, we chose term rather than preterm pla-
centas as normal controls. Although preterm placentas
would match the gestational age of the IUGR and
PEIUGR placentas, they are commonly associated with
pathological processes54,55 and so there is considerable
doubt as to whether they are truly normal. In addition, our
previous results have shown that labor induces signifi-
cant cellular stress within the placenta,56 and non-
labored preterm healthy placentas delivered by elective
caesarean section are almost impossible to obtain. On
the other hand, we did not observe any correlation be-
tween gestational age and any of the data presented
(Figure 1). Furthermore, the IUGR and PEIUGR placen-
tas where differences in the degree of ER stress were
observed were age-matched, eliminating any gestational
age bias.
Protein synthesis is a complex process and can be
divided into three main stages: initiation, elongation, and
termination. Regulation can occur at either the initiation or
elongation stages, and can be controlled via signal trans-
duction pathways.38 We observed three mechanisms by
which initiation may be suppressed in the IUGR
placentas.
Firstly, eIF2 binds GTP and Met-tRNAi and transfers
Met-tRNA to the 40S subunit to form the 43S pre-initiation
complex. It is converted to eIF2.GDP in the process.
eIF2B, a guanine nucleotide exchanger, promotes a new
round of translation initiation by regenerating eIF2.GTP.
Phosphorylation of the eIF2 subunit  at Ser51 acts as a
competitive inhibitor of eIF2B, thus blocking recycling of
eIF2 and attenuating translation initiation.57 Four kinases
have been identified that directly phosphorylate eIF2,
including PRKR-like endoplasmic reticulum kinase, gen-
eral control nonderepressible 2, heme-regulated eIF2
kinase, and double-stranded RNA-dependent protein ki-
nase.14 These kinases are activated in response to dif-
ferent stresses: PRKR-like endoplasmic reticulum kinase
by ER stress; general control nonderepressible 2 by
amino acid deprivation; heme-regulated eIF2 kinase by
hemin deficiency; and double-stranded RNA-dependent
protein kinase by viral infection. Based on the molecular
biomarkers we analyzed, the more severe ER stress in
PEIUGR placentas correlated with higher levels of P-
eIF2 (Figure 1A), suggesting a causal link via activation
of PRKR-like endoplasmic reticulum kinase.
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A second mechanism for suppressing translation initi-
ation involves GSK-3 that phosphorylates eIF2B, inhibit-
ing its activity.39,48 In IUGR placentas, we observed a
greater than 90% reduction in GSK-3 phosphorylation,
with only a slight decrease in total protein (Figure 2),
secondary to the reduction of AKT protein. Dephosphor-
ylation of GSK-3 increases its activity, allowing phos-
phorylation of eIF2B.39 eIF2B is composed of five sub-
units, and only the  subunit contains guanine nucleotide
exchange catalytic activity. Therefore, the down-regula-
tion of eIF2B subunit concentration observed in IUGR
placentas indicates a further reduction of eIF2B activity.
The third block to initiation involves 4E-BP1. The eIF4
family of translation factors recruits mRNA to ribosomes
by binding to the 5cap structure of the mRNA and acti-
vating cap-dependent translation initiation.58 The activity
of eIF4E can be regulated by a set of 4E binding proteins
(4E-BPs) including 4E-BP1. 4E-BP1 binds to eIF4E, pre-
venting its interaction with eIF4 family members.59 Phos-
phorylation of 4E-BP1 blocks this interaction. 4E-BP1
contains multiple phosphorylation sites, including Thr37/
46, Thr70, Ser65, and Ser101.60 Although phosphoryla-
tion of Thr37/46 does not regulate the binding of 4E-BP1
to eIF4E directly, it is required for modification of Thr70,
following which Ser65 undergoes phosphorylation.60–63
Therefore, the phosphorylation level of Thr37/46 can be
used as a reporter for 4E-BP1 binding activity. Our ob-
servation of greatly decreased P-4E-BP1 at Thr37/46 in
IUGR placentas without a change in total protein concen-
tration thus indicates suppression of cap-dependent ini-
tiation of translation.
Our data confirm reduced mTOR signaling in IUGR.
Indeed, the decreases in mTOR, TSC2, and raptor pro-
tein concentrations suggest that eIF2 operates up-
stream of the mTOR pathway, providing an overarching
mechanism that ensures stress-induced attenuation of
initiation of protein translation even in nutrient-rich condi-
tions. Consistent with this, we observed a significant re-
duction of P-4E-BP1, as well as of P-TSC2 in Akt1 null
mouse placentas (Figure 4).
The elongation stage of protein synthesis is controlled
by the eukaryotic elongation factors (eEFs). eEF2 is phos-
phorylated at Thr56 by eEF2 kinase (eEF2K), impairing its
interaction with the ribosome and thus inactivating elon-
gation.64 The activity of eEF2K can be regulated by S6
kinases.35 Phosphorylation of eEF2K at Ser366 by S6Ks
impairs its activity and hence favors activation of trans-
lation.35 In IUGR placentas we observed increased
P-eEF2K, suggesting that S6Ks activity was maintained
through other pathways, despite the reduction in mTOR
signaling. This increased phosphorylation, coupled with
the reduction in total eEF2K, suggests that the elongation
process still functions in these placentas.
These results may explain the apparent paradox that
proteins involved in stress responses, including GRP78,
GRP94, CHOP and activating transcription factor 4, can
bypass translation inhibition in the presence of P-eIF2
and increase in concentration.14 Other placental pro-
teins, such as leptin and N-myc down-regulated gene 1,
are also markedly increased in both IUGR and pre-
eclampsia, and the associated rise in their mRNAs sug-
gests a combination of both transcriptional and transla-
tional activation occurs.65,66 It has been reported that
mRNAs containing small upstream open reading frames
within their 5-UTR regions or internal ribosome entry
sites sequences are selectively translated independent
of eIF2 regulation,67,68 although the latter is conten-
tious.69 Genomic sequence analysis revealed that the
genes mentioned above contain either upstream open
reading frames or internal ribosome entry sites, or
both68,70,71 (unpublished data).
The syncytiotrophoblast layer of the human placenta is
crucial for normal placental function. All secretory pro-
teins require posttranslational modifications inside the ER
lumen before passage to the Golgi apparatus for secre-
tion. Any disturbance of the ER environment will induce
unfolded protein response, influencing placental secre-
tion of autocrine, paracrine and endocrine factors. Such
perturbations can have devastating effects on placental
development, and secondarily on the fetus. Thus, dele-
tion of a trophoblast-specific Igf2 transcript, which en-
codes one of the major placental growth factors, insulin-
like growth factor 2, in the mouse results in severe growth
restriction of the placenta, and consequently of the
pups.72 The phenotypes are similar to those seen in
human IUGR.73,74 There is also increasing clinical evi-
dence that during human pregnancy reduced placental
growth precedes fetal growth restriction.2 Therefore, ER
stress-induced placental growth restriction could have a
major impact on fetal growth. Genetic manipulation of
different molecules involved in the ER stress may eluci-
date the mechanisms for ER stress regulated placental
growth. However, Grp78/ mice fail to develop up to
E3.575 while mice with knocked out PRKR-like endoplas-
mic reticulum kinase, Perk/, exhibit normal morphology
at birth,76 suggesting that choosing the right molecule to
study is crucial.
To conclude, our data provide the first molecular
mechanistic explanation for the placental growth restric-
tion seen in pathological pregnancies. We have identified
protein synthesis inhibition as the key element in the
pathophysiology. This also provides a rational explana-
tion for the biochemical changes observed in IUGR preg-
nancies, such as the reduced concentration of circulating
pregnancy-associated plasma protein-A, which may be
useful as a diagnostic biomarker.77 Identification of pro-
tein synthesis inhibition provides a completely new in-
sight into potential therapeutic interventions for IUGR.
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